TWD 60.7
(-2.72%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.39 Billion TWD | -2.46% |
2022 | 1.43 Billion TWD | 22.72% |
2021 | 1.16 Billion TWD | -4.88% |
2020 | 1.22 Billion TWD | -2.72% |
2019 | 1.26 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.54 Billion TWD | 10.39% |
2024 Q2 | 1.73 Billion TWD | 12.4% |
2023 Q4 | 1.39 Billion TWD | 21.39% |
2023 Q3 | 1.15 Billion TWD | -5.26% |
2023 FY | 1.39 Billion TWD | -2.46% |
2023 Q2 | 1.21 Billion TWD | 4.85% |
2023 Q1 | 1.16 Billion TWD | 0.0% |
2022 Q4 | - TWD | 0.0% |
2022 FY | 1.43 Billion TWD | 22.72% |
2021 FY | 1.16 Billion TWD | -4.88% |
2020 FY | 1.22 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 32.664% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -19.099% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -15.33% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 85.824% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 88.065% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 87.052% |
Center Laboratories, Inc. | 27 Billion TWD | 94.816% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -114.034% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 45.375% |
InnoPharmax Inc. | 524.19 Million TWD | -167.049% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | 29.759% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | 11.251% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | 22.773% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | 24.797% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 53.909% |
UniPharma Co., Ltd. | 350.07 Million TWD | -299.875% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 36.903% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -43.84% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -74.595% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -219.548% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -157.968% |